The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 29, No. 11, pp. 1110-1114.
© 1995 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laine, G.
Right arrow Articles by Adams, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laine, G.
Right arrow Articles by Adams, S.

Research Articles

Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam

GA Laine, SM Hossain, RT Solis, and SC Adams

OBJECTIVE: To report a patient with a probable acute tubular necrosis (ATN) induced by chronic exposure to polyethylene glycol (PEG)-400 via long-term, massive dosage of intravenous lorazepam. CASE SUMMARY: A 57-year-old man with a history of alcohol abuse was admitted to the intensive care unit for acute respiratory failure. Lorazepam therapy was initiated in anticipation of alcohol withdrawal. Dosages up to 18 mg/h were required to provide adequate sedation and optimize ventilation. On day 43, the patient developed oliguric ATN of unknown etiology. The cumulative intravenous lorazepam dose was 4089 mg, equivalent to approximately 220 mL of PEG-400. Blood urea nitrogen concentrations followed a pattern that paralleled lorazepam dosage increases and decreases. Protein and granular casts were evident in urinalyses performed on days 12 and 29. The patient eventually experienced complete recovery. DISCUSSION: ATN associated with intravenous PEG was last reported in 1959 in 6 of 32 patients receiving a cumulative PEG-300 dose of 120-200 mL over 3-5 days via an intravenous nitrofurantoin preparation. Two of the 6 patients died. Chronic administration of intravenous PEG to rabbits over a 5-week period has caused cloudy swelling of the renal tubular epithelium, increased blood urea concentrations, and death in some animals. CONCLUSIONS: ATN probably resulted from chronic PEG exposure via massive doses of lorazepam injection, possibly enhanced by concurrent administration of vancomycin.


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
R. Webster, E. Didier, P. Harris, N. Siegel, J. Stadler, L. Tilbury, and D. Smith
PEGylated Proteins: Evaluation of Their Safety in the Absence of Definitive Metabolism Studies
Drug Metab. Dispos., January 1, 2007; 35(1): 9 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
K Subramaniam, R M Gowda, K Jani, W Zewedie, and R Ute
Propofol combined with lorazepam for severe poly substance misuse and withdrawal states in intensive care unit: a case series and review
Emerg. Med. J., September 1, 2004; 21(5): 632 - 634.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. Tayar, G. Jabbour, and S. J. Saggi
Severe Hyperosmolar Metabolic Acidosis Due to a Large Dose of Intravenous Lorazepam
N. Engl. J. Med., April 18, 2002; 346(16): 1253 - 1254.
[Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1995 by Harvey Whitney Books Company.